DK1617876T3 - Thorium-227 til anvendelse i strålebehandling af bløddels-sygdomme - Google Patents

Thorium-227 til anvendelse i strålebehandling af bløddels-sygdomme

Info

Publication number
DK1617876T3
DK1617876T3 DK04727587.0T DK04727587T DK1617876T3 DK 1617876 T3 DK1617876 T3 DK 1617876T3 DK 04727587 T DK04727587 T DK 04727587T DK 1617876 T3 DK1617876 T3 DK 1617876T3
Authority
DK
Denmark
Prior art keywords
thorium
radiation treatment
bleeding diseases
bleeding
diseases
Prior art date
Application number
DK04727587.0T
Other languages
English (en)
Inventor
Roy Larsen
Oyvind Bruland
Original Assignee
Algeta As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0308731.9A external-priority patent/GB0308731D0/en
Application filed by Algeta As filed Critical Algeta As
Application granted granted Critical
Publication of DK1617876T3 publication Critical patent/DK1617876T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A61K51/1096—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicinal Preparation (AREA)
DK04727587.0T 2003-04-15 2004-04-15 Thorium-227 til anvendelse i strålebehandling af bløddels-sygdomme DK1617876T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0308731.9A GB0308731D0 (en) 2003-04-15 2003-04-15 Method of radiotherapy
PCT/GB2004/001654 WO2004091668A1 (en) 2003-04-15 2004-04-15 Thorium-227 for use in radiotherapy of soft tissue disease

Publications (1)

Publication Number Publication Date
DK1617876T3 true DK1617876T3 (da) 2014-07-21

Family

ID=35385222

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04727587.0T DK1617876T3 (da) 2003-04-15 2004-04-15 Thorium-227 til anvendelse i strålebehandling af bløddels-sygdomme

Country Status (19)

Country Link
EP (1) EP1617876B1 (da)
JP (2) JP5006032B2 (da)
KR (2) KR20060015507A (da)
CN (1) CN100586484C (da)
AU (1) AU2004229218B2 (da)
BR (1) BRPI0409387B8 (da)
CA (1) CA2522148C (da)
CY (1) CY1115407T1 (da)
DK (1) DK1617876T3 (da)
EA (1) EA008195B1 (da)
ES (1) ES2486845T3 (da)
HK (1) HK1094150A1 (da)
IL (1) IL171148A (da)
MX (1) MXPA05010804A (da)
NO (1) NO332931B1 (da)
NZ (3) NZ543044A (da)
PL (1) PL1617876T3 (da)
PT (1) PT1617876E (da)
ZA (1) ZA200507983B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA008195B1 (ru) * 2003-04-15 2007-04-27 Алгета Ас Применение тория-227 в лучевой терапии заболеваний мягких тканей
GB201002508D0 (en) * 2010-02-12 2010-03-31 Algeta As Product
GB201007354D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method
GB201105298D0 (en) * 2011-03-29 2011-05-11 Algeta Asa Pharmaceutical preparation
GB201600154D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
GB201600153D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
ES2952744T3 (es) 2016-12-15 2023-11-03 Nestle Sa Composiciones y procedimientos que modulan los glóbulos blancos o los neutrófilos en un animal de compañía
FR3088769B1 (fr) * 2018-11-15 2020-12-25 Orano Med Procede de preparation d'au moins un generateur a haute teneur en radium-228
RU2767567C1 (ru) * 2020-10-27 2022-03-17 Станислав Анатольевич Дороватовский Комплексные соединения, содержащие в своем составе радионуклид 227Th, а также бисфосфонатный фрагмент, способы их получения, а также потенциальное применение в качестве действующего вещества в составе остеотропного радиофармацевтического лекарственного препарата

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053196T3 (es) * 1989-06-19 1994-07-16 Akzo Nv Metodo para la produccion de un radioinmunoconjugado.
EP0662842A1 (en) * 1992-04-13 1995-07-19 The Dow Chemical Company Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof
MY133346A (en) * 1999-03-01 2007-11-30 Biogen Inc Kit for radiolabeling ligands with yttrium-90
NO314537B1 (no) * 1999-12-06 2003-04-07 Anticancer Therapeutic Inv Sa Reseptorbindende konjugater
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
CA2381123C (en) * 2000-02-25 2011-10-04 Dangshe Ma Actinium-225 complexes and conjugates for radioimmunotherapy
NO313180B1 (no) * 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Bensökende alfapartikkel emitterende radiofarmasöytika
ITMI20022411A1 (it) * 2002-11-14 2004-05-15 Bracco Imaging Spa Agenti per la diagnosi e la terapia di tumori che espongono sulla superficie delle cellule proteine alterate.
EA008195B1 (ru) * 2003-04-15 2007-04-27 Алгета Ас Применение тория-227 в лучевой терапии заболеваний мягких тканей

Also Published As

Publication number Publication date
EP1617876A1 (en) 2006-01-25
IL171148A (en) 2013-12-31
NO20055390L (no) 2006-01-16
NZ543044A (en) 2010-04-30
KR20060015507A (ko) 2006-02-17
CN1805760A (zh) 2006-07-19
CY1115407T1 (el) 2017-01-04
BRPI0409387A (pt) 2006-04-18
CN100586484C (zh) 2010-02-03
JP5006032B2 (ja) 2012-08-22
MXPA05010804A (es) 2006-03-09
ZA200507983B (en) 2007-03-28
EP1617876B1 (en) 2014-05-14
NZ595758A (en) 2013-02-22
JP5468597B2 (ja) 2014-04-09
BRPI0409387B8 (pt) 2021-05-25
CA2522148A1 (en) 2004-10-28
JP2006523664A (ja) 2006-10-19
KR101274867B1 (ko) 2013-06-13
AU2004229218A1 (en) 2004-10-28
NO20055390D0 (no) 2005-11-15
NO332931B1 (no) 2013-02-04
PL1617876T3 (pl) 2015-03-31
BRPI0409387B1 (pt) 2021-05-11
AU2004229218B2 (en) 2009-05-07
CA2522148C (en) 2010-07-13
KR20110022743A (ko) 2011-03-07
JP2012051942A (ja) 2012-03-15
PT1617876E (pt) 2014-08-04
EA008195B1 (ru) 2007-04-27
EA200501456A1 (ru) 2006-06-30
ES2486845T3 (es) 2014-08-19
NZ606996A (en) 2014-08-29
HK1094150A1 (en) 2007-03-23

Similar Documents

Publication Publication Date Title
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
LTPA2017004I1 (lt) Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
DK1701941T3 (da) Forbindelser til behandling af sygdomme med celleproliferation
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
DK1663287T3 (da) Anvendelse af modificerede cyclosporiner til behandling af HCV-sygdomme
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
DK2308507T3 (da) Fremgangsmåder til behandling af præeklampsi
PT1506781E (pt) Composicao para tratamento vaginal
DK1853271T3 (da) Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme
DK2409728T3 (da) System til ultralydsbehandling af væv
DE602004018587D1 (de) Staubschützende Wegwerfmaske
DK1485127T3 (da) Anvendelse af midler til behandling af inflammation
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
DK1885380T3 (da) Natriummetaarsenit til anvendelse til behandling af metastatiske neoplastiske sygdomme
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1716119T3 (da) Analoger af benzoquinonholdige ansamyciner til behandling af cancer
CY2018006I2 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
DE60311298D1 (de) Kopfhautbehandlung
DK1744781T3 (da) Behandling af infektionssygdomme
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
NO20050689L (no) Terapeutisk anvendelse
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DK1517988T3 (da) Anvendelse af erythropoietin til vævsregenerering in vivo
IS7825A (is) Meðferðarfræðileg meðhöndlun
ATE439843T1 (de) S-mirtazapin zur behandlung von hitzewallungen